Downregulation of Plk1 Expression By Receptor-Mediated Uptake of Antisense Oligonucleotide-Loaded Nanoparticles

This publication has 50 references indexed in Scilit:

• FGF Receptor-mediated Gene Delivery using Ligands Coupled to Polyethylenimine
  Journal of Biomaterials Applications, 2007
• Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane®) on three treatment schedules in patients with solid tumors
  Cancer Chemotherapy and Pharmacology, 2007
• The Small-Molecule Inhibitor BI 2536 Reveals Novel Insights into Mitotic Roles of Polo-like Kinase 1
  Current Biology, 2007
• BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo
  Current Biology, 2007
• Inhibitors of Polo-like kinase reveal roles in spindle-pole maintenance
  Nature Chemical Biology, 2006
• Increased Target Specificity of Anti-HER2 Genospheres by Modification of Surface Charge and Degree of PEGylation
  Molecular Pharmaceutics, 2006
• Molecular alterations after Polo-like kinase 1 mRNA suppression versus pharmacologic inhibition in cancer cells
  Molecular Cancer Therapeutics, 2006
• Polo-like kinases and the orchestration of cell division
  Nature Reviews Molecular Cell Biology, 2004
• Polo-like Kinase 1 (Plk1) Inhibits p53 Function by Physical Interaction and Phosphorylation
  Journal of Biological Chemistry, 2004
• Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes.
  The Journal of cell biology, 1996